Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse modelCLINICAL SCIENCEIF7.72024-09-260OAAI
Mas-related G protein-coupled receptor type D antagonism improves portal hypertension in cirrhotic ratsHEPATOLOGY COMMUNICATIONSIF4.62022-05-206OAAI
Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel TreatmentsFRONTIERS IN PHYSIOLOGYIF3.42022-03-210OAAI
Angiotensin Converting Enzyme-2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty LiverHEPATOLOGY COMMUNICATIONSIF4.62021-12-237OAAI
Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver CirrhosisMOLECULESIF4.62021-08-106OAAI
Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic OptionsJOURNAL OF CLINICAL MEDICINEIF2.92021-02-1128OA
Cirrhotic portal hypertension: From pathophysiology to novel therapeuticsWORLD JOURNAL OF GASTROENTEROLOGYIF5.42020-10-2861OAAI
Liver-Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug-Resistant Gene 2-Knockout MiceHEPATOLOGY COMMUNICATIONSIF4.62019-10-1034OAAI
Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive RatsFRONTIERS IN PHYSIOLOGYIF3.42019-09-208OAAI
Advanced glycation end products (AGEs) exacerbate NAFLD progression to liver fibrosis via receptor for AGEs (RAGE) in high fat fed miceJOURNAL OF HEPATOLOGYIF332019-04-010PREAI
Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver TransplantationJOURNAL OF CLINICAL MEDICINEIF2.92019-03-2723OAAI
The Effects of Diabetes and High-Fat Diet on Polymodal Nociceptor and Cold Thermoreceptor Nerve Terminal Endings in the Corneal EpitheliumINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72019-01-1414OAAI
The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in miceSCIENTIFIC REPORTSIF3.92018-07-0542OAAI
Mas-related G-protein coupled receptor type D (MrgD) antagonism produces splanchnic vasculature-specific effects, leading to a large reduction in portal pressure in cirrhotic animalsJOURNAL OF HEPATOLOGYIF332018-04-010PREAI
Increased liver AGEs induce hepatic injury mediated through an OST48 pathwaySCIENTIFIC REPORTSIF3.92017-09-2523OAAI
The Adeno-associated Virus - A Safe and Promising Vehicle for Liver-specific Gene Therapy of Inherited and Non-inherited DisordersCURRENT GENE THERAPYIF3.32017-07-0627PRE
The alternate renin angiotensin system is upregulated and Ang-(1-7) mediates vasodilatation in human cirrhosisJOURNAL OF HEPATOLOGYIF332017-01-010PREAI
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver diseaseWORLD JOURNAL OF GASTROENTEROLOGYIF5.42016-01-0162OAAI
ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in MiceMOLECULAR THERAPYIF122015-09-0156OAAI